Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 14Oropharyngeal Neoplasms 12Lung Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Mouth Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Small Cell Lung Carcinoma 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Nasopharyngeal Carcinoma 6Mesothelioma, Malignant 6Hypopharyngeal Neoplasms 6Pancreatic Neoplasms 5Triple Negative Breast Neoplasms 4Ganglioneuroblastoma 4Gallbladder Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Neuroblastoma 3Medulloblastoma 3Lymphoid Interstitial Pneumonia 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Adenocarcinoma of Lung 3Testicular Neoplasms 2

Interventions

Taxes 3Paclitaxel 3Immunoglobulin G 3Disulfides 3Carboplatin 3Bevacizumab 3Gemcitabine 2adavosertib 1X-Rays 1Specimen Handling 1Platinum 1Metformin 1Mesenchymal Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Drug Therapy 1Docetaxel 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brenner Tumor × Platinum × 1 year × Clear all
NCT00951496 2026-06-02

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 3 Completed
1,560 enrolled 19 charts

Brenner Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡